Fig. 5
From: The potential of secretogranin V as a prognostic biomarker in non-small cell lung cancer
ROC curves and survival prediction analysis of the SCG5 gene. (A, B) Analyzed the KM database to study the prognostic association of SCG5 expression with overall survival and post-progression survival in patients with LUAD; (C, D) Analyzed the KM database to study the prognostic association of SCG5 expression with overall survival and post-progression survival in patients with LUSC; (E) ROC curves; (F) Kaplan-Meier survival analysis of NSCLC patients with different SCG5 expression levels in immunohistochemistry; (G) Nomogram of predicted 1-3- and 5-year survival rates of lung cancer patients.
